首页> 外文期刊>Proteins: Structure, Function, and Genetics >1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
【24h】

1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.

机译:1.70人载脂蛋白激肽释放酶的X射线结构1:肽抑制剂/底物结合后的结构变化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human kallikreins are serine proteases that comprise a recently identified large and closely related 15-member family. The kallikreins include both regulatory- and degradative-type proteases, impacting a variety of physiological processes including regulation of blood pressure, neuronal health, and the inflammatory response. While the function of the majority of the kallikreins remains to be elucidated, two members are useful biomarkers for prostate cancer and several others are potentially useful biomarkers for breast cancer, Alzheimer's, and Parkinson's disease. Human tissue kallikrein (human K1) is the best functionally characterized member of this family, and is known to play an important role in blood pressure regulation. As part of this function, human K1 exhibits unique dual-substrate specificity in hydrolyzing low molecular weight kininogen between both Arg-Ser and Met-Lys sequences. We report the X-ray crystal structure of mature, active recombinant human apo K1 at 1.70 A resolution. The active site exhibits structural features intermediate between that of apo and pro forms of known kallikrein structures. The S2 to S2' pockets demonstrate a variety of conformational changes in comparison to the porcine homolog of K1 in complex with peptide inhibitors, including the displacement of an extensive solvent network. These results indicate that the binding of a peptide substrate contributes to a structural rearrangement of the active-site Ser 195 resulting in a catalytically competent juxtaposition with the active-site His 57. The solvent networks within the S1 and S1' pockets suggest how the Arg-Ser and Met-Lys dual substrate specificity of human K1 is accommodated.
机译:人激肽释放酶是丝氨酸蛋白酶,其包含最近鉴定的大且密切相关的15成员家族。激肽释放酶既包括调节型蛋白酶也包括降解型蛋白酶,影响多种生理过程,包括调节血压,神经元健康和炎症反应。尽管大多数激肽释放酶的功能尚待阐明,但有两个成员是前列腺癌的有用生物标志物,而其他几个成员是乳腺癌,阿尔茨海默氏病和帕金森氏病的潜在有用生物标志物。人体组织激肽释放酶(人类K1)是该家族中功能最佳的成员,并且已知在血压调节中起重要作用。作为此功能的一部分,人K1在水解Arg-Ser和Met-Lys序列之间的低分子量激肽原时表现出独特的双重底物特异性。我们报告了成熟,活跃的重组人载脂蛋白K1在1.70 A分辨率的X射线晶体结构。活性位点的结构特征介于载脂蛋白和已知激肽释放酶结构的原形式之间。与具有肽抑制剂的K1的猪同源物相比,S2到S2'的口袋显示出各种构象变化,包括置换广泛的溶剂网络。这些结果表明,肽底物的结合有助于活性位点Ser 195的结构重排,从而导致与活性位点His 57的催化作用并列。S1和S1'口袋中的溶剂网络表明Arg如何容纳人K1的-Ser和Met-Lys双重底物特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号